Design, synthesis and biological evaluation of shikonin thio-glycoside derivatives: new anti-tubulin agents
Design, synthesis and biological evaluation of shikonin thio-glycoside derivatives: new anti-tubulin agents
复制标题
DOI:
10.1039/c4ra08810g
复制
发表时间:
2014-10
期刊:
影响因子:
3.9
通讯作者:
Hongyan Lin;H. Han;Li-Fei Bai;Han‐Yue Qiu;Deyan Yin;J. Qi;Xiao-Ming Wang;H. Gu;Yong-Hua Yang-Yong-Hua
中科院分区:
文献类型:
--
作者:
Hongyan Lin;H. Han;Li-Fei Bai;Han‐Yue Qiu;Deyan Yin;J. Qi;Xiao-Ming Wang;H. Gu;Yong-Hua Yang-Yong-Hua
A novel series of acetyl-β-D-thio-glycoside modified shikonin derivatives were designed and synthesized and investigated for inhibition of cell proliferation against MG63, MCF-7, B16-F10, HepG2, MDA-231, L02, VERO and MCF-10A cell lines. The biological study showed that most single, di- and tri-substituted shikonin derivatives exhibited better anti-proliferative activities against the five cancer cell lines but lower cytotoxic activity against normal cells than shikonin itself. Notably, compared to shikonin, IIb displayed much stronger anti-proliferative effect among them. Furthermore, the inhibition of tubulin polymerization results indicated that IIb showed the most potent anti-tubulin activity (IC50 = 4.67 ± 0.433 μM), which was compared with shikonin (IC50 = 16.8 ± 0.625 μM) and colchicine (IC50 = 3.83 ± 0.424 μM). Docking simulation, confocal microscopy and western bolt results further confirmed that IIb can cause cell arrest in G2/M phase and induce cell apoptosis via binding to the active site of tubulin and inhibiting tubulin polymerization.